<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Nano Lipid Delivery System</title>
    <link rel="stylesheet" href="../../../styles/main.css">
</head>
<body>
    <div class="container">
        <h1>üî¨ Nano Lipid Delivery System</h1>
        
        <div style="background: #e3f2fd; padding: 15px; border-radius: 5px;">
            <h2>üéØ System Design</h2>
            <h3>Nano Lipid Structure</h3>
            <ul>
                <li><strong>Size:</strong> 20-50nm diameter particles</li>
                <li><strong>Composition:</strong> Modified phospholipids</li>
                <li><strong>Surface:</strong> BBB-optimized properties</li>
                <li><strong>Targeting:</strong> AlF/AlF3-specific elements</li>
            </ul>

            <h3>Functional Components</h3>
            <ul>
                <li><strong>Phosphate Groups:</strong> Antagonist binding domains</li>
                <li><strong>Stability Enhancers:</strong> Physiological protection</li>
                <li><strong>Clearance Facilitators:</strong> Safe elimination</li>
                <li><strong>Safety Features:</strong> Biocompatibility elements</li>
            </ul>
        </div>

        <div style="background: #f0f8f0; padding: 15px; border-radius: 5px; margin: 15px 0;">
            <h2>üöÄ Delivery Performance</h2>
            <h3>Blood-Brain Barrier Transit</h3>
            <ul>
                <li><strong>Crossing Efficiency:</strong> >95%</li>
                <li><strong>Distribution:</strong> Rapid neural tissue reach</li>
                <li><strong>Barrier Integrity:</strong> Minimal disruption</li>
                <li><strong>Sustained Presence:</strong> Extended action window</li>
            </ul>

            <h3>Target Engagement</h3>
            <ul>
                <li><strong>Recognition:</strong> Specific AlF/AlF3 binding</li>
                <li><strong>Complex Formation:</strong> Stable sequestration</li>
                <li><strong>Clearance Rate:</strong> >90% compound removal</li>
                <li><strong>Duration:</strong> 12+ month sustained effect</li>
            </ul>
        </div>

        <div style="background: #fff8e1; padding: 15px; border-radius: 5px;">
            <h2>üìã Administration Protocol</h2>
            <ul>
                <li><strong>Route:</strong> Intravenous delivery</li>
                <li><strong>Initial Phase:</strong> Weekly √ó 4 weeks</li>
                <li><strong>Maintenance:</strong> Monthly √ó 3-6 months</li>
                <li><strong>Monitoring:</strong> Real-time compound tracking</li>
            </ul>
        </div>

        <p><a href="index.html">‚Üê Back to Research Index</a></p>
    </div>
</body>
</html>